Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $50,094.05 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 48,635 shares of the stock in a transaction that occurred on Thursday, May 16th. The shares were acquired at an average cost of $1.03 per share, for a total transaction of $50,094.05. Following the completion of the transaction, the chief executive officer now owns 14,417,148 shares of the company’s stock, valued at approximately $14,849,662.44. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Retractable Technologies Price Performance

NYSE:RVP opened at $0.92 on Thursday. The company has a quick ratio of 8.18, a current ratio of 11.02 and a debt-to-equity ratio of 0.01. Retractable Technologies, Inc. has a 52 week low of $0.87 and a 52 week high of $1.34. The firm’s 50-day simple moving average is $1.10 and its 200 day simple moving average is $1.14.

Retractable Technologies (NYSE:RVP) last announced its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $7.60 million for the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC grew its stake in Retractable Technologies, Inc. (NYSE:RVP) by 27.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 126,533 shares of the company’s stock after purchasing an additional 27,500 shares during the period. WealthTrust Axiom LLC owned about 0.42% of Retractable Technologies worth $151,000 as of its most recent filing with the Securities and Exchange Commission. 7.58% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com started coverage on shares of Retractable Technologies in a research report on Sunday. They set a “hold” rating on the stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.